Search results
New PET agent provides same-day imaging for clear cell renal cell carcinoma patients
Medical Xpress· 2 days agoA novel investigational PET imaging agent can rapidly and accurately visualize lesions in clear cell renal cell cancer (ccRCC) patients ...
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients - British...
Nature· 6 days agoTregs trafficking is controlled by CXCR4. In Renal Cell Carcinoma (RCC), the effect of the new CXCR4 antagonist, R54, was explored in ...
Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 3 days agoInvestors' focus will likely be on Iovance's (IOVA) progress with its ongoing commercial launch for...
Fighting Cancer: A Basic Guide To Checkpoint Inhibitors
Forbes· 4 days agoThis article is part of an ongoing series on novel cancer advances, including immunotherapies such...
Bavencio Side Effects: What They Are and How to Manage Them
Healthline· 2 days agoBavencio (avelumab) is a prescription drug used to treat certain types of kidney, bladder, and skin cancer. Bavencio can cause side effects that range from mild to serious. Examples include ...
Nexavar Dosage: Form, Strength, How to Take, and More
Healthline· 3 days agoNexavar (sorafenib) is a prescription drug used to treat liver, kidney, and thyroid cancers. Nexavar belongs to a group of drugs called kinase inhibitors and contains the active ingredient sorafenib ...
HC Wainwright Reaffirms Buy Rating for Exelixis (NASDAQ:EXEL)
ETF DAILY NEWS· 4 days agoHC Wainwright reaffirmed their buy rating on shares of Exelixis (NASDAQ:EXEL – Free Report) in a research report sent to investors on Friday, Benzinga reports. Several other equities analysts ...
New York State Common Retirement Fund Sells 5,141 Shares of Iovance Biotherapeutics, Inc....
ETF DAILY NEWS· 7 days agoNew York State Common Retirement Fund trimmed its holdings in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 0.5% during the 4th quarter, according to the company in ...
Retirement Systems of Alabama Sells 8,056 Shares of Exelixis, Inc. (NASDAQ:EXEL)
ETF DAILY NEWS· 7 days agoRetirement Systems of Alabama cut its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 2.0% during the fourth quarter, according to the company in its most recent disclosure ...
Headlands Technologies LLC Has $32,000 Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL)
ETF DAILY NEWS· 7 days agoHeadlands Technologies LLC cut its stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 70.6% in the 4th quarter, Holdings Channel.com reports. The fund owned 1,341 shares of the biotechnology ...
